A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced withdrawal symptoms when given GLP-1 therapy. In the case study published ...

But not everyone will need such a high dose to achieve their weight loss goals. It’s not uncommon to experience some adverse effects with semaglutide, especially during the first few weeks of ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., also had been resolved. Zepbound is approved to treat obesity and Mounjaro ...

Research found that semaglutide, the active substance in Ozempic and the weight-loss drug Wegovy, could help curb alcohol ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide ... in weight in the REDEFINE 1 study over 68 weeks that fell short of Novo Nordisk's hope of a 25% loss.

Madison Burgess turned to Ozempic for weight loss in 2023. She saw quick results but developed severe side effects when her dose increased. Switching to microdosing, she ultimately lost 60 lbs.

Published on Wednesday in JAMA Psychiatry, a study involving 48 individuals showing signs of moderate alcohol-use disorder ...

About 12% of Americans have ... who were treated with semaglutide for 68 weeks had significantly less knee pain than those receiving a placebo. Weight loss that resulted from the drug was probably ...